In the present study, bfl-1 mRNA levels have been quantified by competitive PCR in an extended population of B-CLL patients to characterise its role in disease progression and development of chemoresistance. The gene discussed is BCL2A1; the disease is B-cell chronic lymphocytic leukemia.